ICD-10-CM Billable Code

Z16.11

Resistance to penicillins

Clinical Classification Guidelines

Inclusion Terms

  • Resistance to amoxicillin
  • Resistance to ampicillin

Medical Intelligence & Overview

Resistance to penicillins, including amoxicillin and ampicillin, is a situation where bacteria develop the ability to survive despite the presence of these antibiotics. This resistance can make infections harder to treat and may lead to prolonged illness or complications. Recognizing and understanding this resistance is crucial for effective healthcare management and antibiotic use.

Causes & Symptoms

Clinical Causes: Overuse or inappropriate use of antibiotics can promote bacterial resistance. Genetic mutations in bacteria that alter drug targets or enhance drug efflux. Horizontal transfer of resistance genes between bacteria through plasmids or other mechanisms. Incomplete courses of antibiotic therapy, leading to survival of resistant bacteria. Environmental contamination with resistant bacteria, facilitating spread.

Key Symptoms: Persistent or recurrent bacterial infections despite antibiotic treatment. Symptoms indicative of the underlying infection, such as fever, pain, or swelling, may not improve with standard antibiotics. Increased severity or duration of illness. Potential spread of resistant bacteria to others, leading to outbreaks of resistant infections.

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves microbiological testing, such as bacterial culture and sensitivity testing, to determine if the bacteria causing the infection are resistant to penicillins like amoxicillin and ampicillin. Healthcare providers assess the patient’s medical history, previous antibiotic use, and response to treatment, supplemented by laboratory results to confirm resistance.

Treatment Protocols: Managing penicillin-resistant bacterial infections often requires alternative antibiotics to which the bacteria are susceptible. Treatment plans may include using other classes of antibiotics, such as cephalosporins, macrolides, or fluoroquinolones, depending on susceptibility profiles. Infection control measures and prudent antibiotic prescribing are essential to prevent further resistance development.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z16.11 a billable ICD-10 code?
Yes, Z16.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z16.11?
Clinical documentation must specify the nature of Resistance to penicillins and any associated comorbidities for accurate reporting.

Cite this Clinical Reference